The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

Phillips Thygeson Lectures

Thygeson Lecturer Title Date
Membership OMIG is dedicated to Phillips Thygeson 10/30/82
Dan Jones, MD Emerging Antibiotic Resistance in Ocular Infections: Real and Relative 10/28/95
Robert Hendricks, PhD Cell Regulation of Herpes Simplex  Virus-Induced Corneal Inflammation 10/26/96
Gilbert Smolin, MD. Ocular Allergy 10/25/97
Richard J. O'Callaghan, PhD The Role of Bacterial Exoproteins in Experimental Staphylococcus and Pseudomonas Keratitis 11/7/98
Panel Vancomycin Prophylaxis Mini-symposium 10/23/99
Jerry Niederkorn, PhD New insights into the Mechanism or Corneal Graft Rejection 10/21/00
Jules Baum, MD Amniotic Membrane Transplantation - Is it Effective? 11/10/01
Gregory Schultze, PhD Molecular Approaches in the Treatment of Ulcerative Keratitis 10/19/02
Richard Forster, MD The Correlation of Microbiology and Pathology in Experimental Endophthalmitis as a Prelude to Focused Therapy 11/15/03
Linda Hazlett, PhD Pseudomonas aeruginosa: Models and Treatment of the Disease 10/23/04
Deborah Langston, MD Herpes Zoster Neurotrophic Keratopathy 10/15/05
William T. Driebe, Jr., MD Contact Lens Related Ulcerative Keratitis 11/10/06
Sally Atherton, PhD Herpes Simplex Virus Infections:
From Outside In?
Y. Jerold Gordon, MD The Life and Times of Adenovirus 1899 - 2008 11/07/08
Todd P Margolis, MD, PhD The Establishment of Latent Infection with Herpes Simplex Virus 10/23/09
Thomas Liesegang, MD The Varicella Zoster Virus - Translating research in other medical fields to Ophthalmology 10/15/10
Suzanne M. Fleiszig, OD, PhD, FAAO Pseudomonas aeruginosa versus ocular surface: Who wins and why? 10/21/11
John Sutphin, MD Confocal Microscopy and the Cornea 11/9/12
Michael Gilmore, PhD Understanding Epidemic Bacterial Conjunctivitis through Comparative Genomics 11/15/13
Reza Dana, MD, MSc, MPH What Have We Learned About Alloimmunity and Autoimmunity From Experimental Cornea Models? 10/17/14

Eric Pearlman, PhD

New insights into the pathogenesis of fungal keratitis

James Chodosh, MD, MPH Pink Eye and the Evolution of New Human Adenoviruses 10/14/16
James V. Jester, MD Meibomian Gland Dysfunction: A Meibocyte Centric Hypothesis 11/10/17
Victor L. Perez, MD Strategies to Induce Immune Tolerance for High Risk Corneal Transplants 10/26/18
Darlene Miller, DHSc, MPH Acanthamoeba and Keratitis ... More than Meets the Eye 10/11/19
Stephen C. Pflugfelder, MD Meibomian Gland Dysfunction: A Meibocyte Centric Hypothesis 11/13/20
Michelle C. Callegan, PhD, FARVO Targeting Innate Immune Pathways in Bacterial Endophthalmitis 11/12/21
Ana Luisa H�fling-Lima, MD The Role of Photoactivated Chromophores in the Treatment of Infectious Keratitis 9/30/22
Cintia S. de Paiva, MD, PhD Gut microbiome and Sjogren-Syndrome 11/3/23

Top of Page



OMIG logo
Image of Ocular Microbiology and Immunology Group (OMIG) logo